Capillary Technologies India’s Rs 877 crore IPO opens today. The Bengaluru-based firm is a leader in customer engagement and loyalty management. The IPO includes fresh issuance and offer-for-sale components. Funds will support growth and technology investments. The issue closes this week, with listing expected on November 21.Read More
The dollar weakened against major currencies, heading for a weekly fall as investors anticipate poor U.S. economic data following the government shutdown. This data deluge may prompt the Federal Reserve to slow interest rate cuts, impacting market expectations. Sterling also declined amid fiscal uncertainty, while the yen and Australian dollar faced pressure.Read More
Gold prices saw a slight increase on Friday, poised for a weekly gain due to a weaker dollar. However, hawkish remarks from Federal Reserve officials tempered optimism for a December interest rate cut. Traders are now pricing in a lower probability of further easing, impacting gold’s appeal.Read More
Wall Street experienced significant declines on Thursday, driven by steep losses in AI heavyweights like Nvidia. Investors scaled back expectations of interest rate cuts due to inflation concerns and differing views among central bankers on the U.S. economy’s health. This sentiment led to a market rotation away from technology stocks.Read More
As Bihar election counting commences, Dalal Street braces for volatility, anticipating three scenarios: NDA win, hung assembly, or opposition upset. While a comfortable NDA victory signals policy stability and a mild rally, a closer contest or defeat could trigger short-term swings. However, the broader market trend is expected to remain intact, driven by macro factors.Read More
Curis Lifesciences is set to list on the NSE SME platform on November 14, following an IPO that saw overwhelming investor response, subscribing 74.39 times. The company, which manufactures pharmaceutical formulations, reported strong financial growth in FY25. IPO proceeds will fund facility upgrades, working capital, and market expansion.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
